News

Published on 14 Nov 2023 on Insider Monkey via Yahoo Finance

10 Best Performing Healthcare ETFs in 2023


Article preview image

In this piece, we will take a look at the ten best performing healthcare ETFs in 2023. If you want to skip our overview of the healthcare sector, then take a look at the 5 Best Performing Healthcare ETFs in 2023.

The healthcare industry is one of the biggest in the world. It is also one of the most unique sectors on the stock market, as healthcare stocks are made of both consumer discretionary and cyclical firms. This often means that during a time of economic turmoil, the broader healthcare sector can lag broader stock indexes in losses as the defensive portion hedges losses. For those out of the loop, defensive stocks are those companies that sell essential products such as food. Cyclical stocks are growth stocks that perform well when the economy is growing. To learn more about defensive and cyclical stocks, you can check out 12 Defensive Healthcare Dividend Stocks To Invest In and 11 Best Consumer Cyclical Stocks To Buy Now.

Within the healthcare sector, mega pharma giants such as Pfizer Inc. (NYSE:PFE) are somewhat defensive. This is because these firms often sell drugs that are essential for the normal daily functioning of people with chronic diseases such as hypertension and diabetes. On the flip side, the cyclical sector of the healthcare industry involves high risk and high growth firms such as biotechnology and genomic companies. These firms, such as Moderna, Inc. (NASDAQ:MRNA) and CRISPR Therapeutics AG (NASDAQ:CRSP), often invest millions of dollars in developing new technology often years before they can secure regulatory approval and turn a profit.

NASDAQ.MRNA price evolution
NASDAQ.ICPT price evolution
NASDAQ.CRSP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Jefferies Group's Strategic Moves: A Deep Dive into Allstate Corp's Significant Reduction

Insights from Jefferies Group (Trades, Portfolio)'s Latest 13F Filing for Q3 2023 Warning! GuruFo...

GuruFocus.com via Yahoo Finance 14 Nov 2023

10 Best Performing Healthcare ETFs in 2023

In this piece, we will take a look at the ten best performing healthcare ETFs in 2023. If you wan...

Insider Monkey via Yahoo Finance 14 Nov 2023

Dow Tumbles 150 Points; US House Prices Rise in July - Conduit Pharmaceuticals (NASDAQ:CDT), Femasys...

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. F...

Benzinga 26 Sep 2023

Intercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Y

Intercept Pharmaceuticals ICPT incurred a loss of 14 cents per share (from continuing operations)...

Zacks via Yahoo Finance 2 Aug 2023

Intercept (ICPT) to Restructure Operations, Cut Workforce

Intercept Pharmaceuticals, Inc. ICPT announced a restructuring program in the wake of the recent ...

Zacks via Yahoo Finance 26 Jun 2023

Intercept (ICPT) NDA for NASH Treatment Gets CRL From FDA

Intercept Pharmaceuticals, Inc. ICPT announced that the FDA issued a complete response letter (CR...

Zacks via Yahoo Finance 23 Jun 2023

Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT) Shift From Loss To Profit

We feel now is a pretty good time to analyse Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT) busi...

Simply Wall St. via Yahoo Finance 31 May 2023

The Rising Challenge for Intercept Pharmaceuticals: Analyst Downgrade Amid Ocaliva's DILI Concerns...

Canaccord Genuity has lowered the price target for Intercept Pharmaceutical Inc (NASDAQ: ICPT) fr...

Investing.com 23 May 2023

Intercept (ICPT) NASH Treatment Fails to Get GIDAC Recommendation

Intercept Pharmaceuticals, Inc. ICPT announced that the FDA’s Gastrointestinal Drugs Advisory Com...

Zacks via Yahoo Finance 22 May 2023

Intercept Pharma Stock Tumbles: FDA Panel Votes Against Intercept's Fatty Liver Drug, Dashing Its...

FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benef...

Benzinga via Yahoo Finance 22 May 2023